Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit

v3.23.1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative effect adjustment for ASC 842 lease accounting adoption
Warrants
Private Placement
At-The-Market Offering
Parent
Parent
Cumulative effect adjustment for ASC 842 lease accounting adoption
Parent
Warrants
Parent
Private Placement
Parent
At-The-Market Offering
Preferred Stock Issued
Common Stock Issued
Common Stock Issued
Warrants
Common Stock Issued
Private Placement
Common Stock Issued
At-The-Market Offering
Additional Paid-In Capital
Additional Paid-In Capital
Warrants
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
At-The-Market Offering
Accumulated Deficit
Accumulated Deficit
Cumulative effect adjustment for ASC 842 lease accounting adoption
Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2021                     0                      
Beginning balance at Aug. 31, 2021 $ 40,923 $ 608       $ (6,549) $ 608       $ 0 $ 3       $ 142,786       $ (149,338) $ 608 $ 47,472
Beginning balance (in shares) at Aug. 31, 2021                       25,863,099                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Common stock issued for convertible securities (in shares)                         4,948,453                  
Common stock issued for convertible securities     $ 5,409         $ 5,409                 $ 5,409          
Common stock issued, net of offering costs (in shares)                           2,850,000                
Common stock issued, net of offering costs       $ 4,183         $ 4,183                 $ 4,183        
Prefunded warrants from private placement, net of offering costs 6,861         6,861                   6,861            
Stock-based compensation expense 747         747                   747            
Excess of proceeds from the sale of private placement warrants to Sponsor (13,270)         (13,270)                   (13,270)            
Withdrawal of SPAC registrations under Form S-1 (37,978)                                         (37,978)
Net loss (18,210)         (18,210)                           (18,210)    
Ending balance (in shares) at Feb. 28, 2022                     0                      
Ending balance (in shares) at Feb. 28, 2022                       33,661,552                    
Ending balance at Feb. 28, 2022 (10,727)         (20,221)         $ 0 $ 3       146,716       (166,940)   9,494
Beginning balance (in shares) at Nov. 30, 2021                     0                      
Beginning balance at Nov. 30, 2021 30,392 $ 608       (17,080) $ 608       $ 0 $ 3       140,968       (158,051) $ 608 47,472
Beginning balance (in shares) at Nov. 30, 2021                       28,713,099                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Common stock issued for convertible securities (in shares)                         4,948,453                  
Common stock issued for convertible securities     5,409         5,409                 5,409          
Stock-based compensation expense 339         339                   339            
Withdrawal of SPAC registrations under Form S-1 (37,978)                                         (37,978)
Net loss (9,497)         (9,497)                           (9,497)    
Ending balance (in shares) at Feb. 28, 2022                     0                      
Ending balance (in shares) at Feb. 28, 2022                       33,661,552                    
Ending balance at Feb. 28, 2022 $ (10,727)         (20,221)         $ 0 $ 3       146,716       (166,940)   9,494
Beginning balance (in shares) at Aug. 31, 2022 8,600,000                   8,600,000                      
Beginning balance at Aug. 31, 2022 $ (31,494)         (40,988)         $ 1 $ 5       151,731       (192,725)   9,494
Beginning balance (in shares) at Aug. 31, 2022 513,349                     513,349                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Fair Market value increase of preferred stock prior to reverse stock split $ 127,145         127,145                   127,145            
Preferential dividend of preferred stock (127,145)         (127,145)                   (127,145)            
Common stock issued for convertible securities (in shares)                     (8,600,000) 8,600,000 124,204                  
Common stock issued for convertible securities 0   $ 1     0   $ 1     $ (1) $ 1         $ 1          
Common stock issued, net of offering costs (in shares)                           416,667 305,340              
Common stock issued, net of offering costs 1,434     $ 4,387   1,434     $ 4,387             1,434   $ 4,387        
Stock-based compensation expense 500         500                   500            
Warrant modification expense 106         106                   106            
Additional Shares issued due to reverse stock split (in shares)                       16,976                    
Deconsolidation of VIE 540         10,034                   10,034           (9,494)
Net loss $ (11,192)         (11,192)                           (11,192)    
Ending balance (in shares) at Feb. 28, 2023 0                   0                      
Ending balance (in shares) at Feb. 28, 2023 9,976,536                     9,976,536                    
Ending balance at Feb. 28, 2023 $ (35,718)         (35,718)         $ 0 $ 6       168,193       (203,917)   0
Beginning balance (in shares) at Nov. 30, 2022                     0                      
Beginning balance at Nov. 30, 2022 (32,168)         (41,662)         $ 0 $ 6       156,480       (198,148)   9,494
Beginning balance (in shares) at Nov. 30, 2022                       9,671,196                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Common stock issued, net of offering costs (in shares)                             305,340              
Common stock issued, net of offering costs         $ 1,434         $ 1,434                 $ 1,434      
Stock-based compensation expense 245         245                   245            
Deconsolidation of VIE 540         10,034                   10,034           (9,494)
Net loss $ (5,769)         (5,769)                           (5,769)    
Ending balance (in shares) at Feb. 28, 2023 0                   0                      
Ending balance (in shares) at Feb. 28, 2023 9,976,536                     9,976,536                    
Ending balance at Feb. 28, 2023 $ (35,718)         $ (35,718)         $ 0 $ 6       $ 168,193       $ (203,917)   $ 0